As Osiris moves on from fraudulent past, one exec settles up with SEC
Two years after the SEC charged four Osiris Therapeutics execs for cooking the books to fabricate a rosy picture at the company, federal regulators have handed down their first judgment.
Bobby Dwayne Montgomery, the former chief business officer at Osiris, has agreed to pay a civil penalty of $40,000 and be legally barred from future violations of securities laws, including those that prohibit falsifying books and records and lying to auditors.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.